SCHEMBL795326

SCHEMBL795326

c1ncn2ncnc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL334940 0.64
SCHEMBL23817294 0.62 PDE10A (0.42)
SCHEMBL23143459 0.61 KDR (0.54)
SCHEMBL18952898 0.57
SCHEMBL958858 0.54
SCHEMBL4067471 0.53
SCHEMBL11296536 0.51
SCHEMBL2532418 0.51 CYP19A1 (0.32)
SCHEMBL373166 0.48 HSP90AA1 (0.50)
SCHEMBL21578108 0.47 HSP90AA1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745154-B1 MULTICOMPONENT SYSTEM FOR MODIFYING, DECOMPOSING OR BLEACHING LIGNIN, LIGNIN-CONTAINING MATERIALS OR SIMILAR SUBSTANCES AND METHOD OF USING THIS SYSTEM LIGNOZYM GMBH (DE) 1998-09-16 EP claimed
WO-1997034891-A1 SUBSTITUTED 1,3-THIAZOLIDINES AND 1,3-THIAZOLIDIN-4-ONES, METHOD FOR PREPARING SAME, AND USE THEREOF AS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1997-09-25 WO claimed
JP-1228991-A None JP disclosed
CN-122010947-A Antagonists of adenosine A2a receptors 阿道尔克斯治疗有限公司 2026-05-12 CN disclosed
CN-118853594-A Chimeric poxvirus compositions and uses thereof 希望之城 2024-10-29 CN disclosed
CN-118834840-A Chimeric poxvirus compositions and uses thereof 希望之城 2024-10-25 CN disclosed
US-20240217978-A1 COMPOUND AS ADENOSINE A2a RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2024-07-04 US disclosed
US-12012467-B2 Small molecule DCN1 inhibitors and therapeutic methods using the same REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-06-18 US disclosed
CN-117701562-A RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL 3) and methods of use 箭头药业股份有限公司 2024-03-15 CN disclosed
EP-4326724-A1 COMPOUND AS ADENOSINE A2A RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2024-02-28 EP disclosed
CN-111343994-B RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL 3) and methods of use 箭头药业股份有限公司 2023-11-21 CN disclosed
JP-H01228991-A SUBSTITUTED 1,2,4-TRIAZOLO(1,5-A)TRIAZINE AS BRONCHODILATOR RIKER LAB INC 1989-09-12 JP disclosed
EP-0281367-A1 Substituted 1,2,4-triazolo[1,5-a]triazines as bronchodilators RIKER LABORATORIES, INC. (US) 1988-09-07 EP disclosed
EP-0281367-A1 Substituted 1,2,4-triazolo[1,5-a]triazines as bronchodilators RIKER LABORATORIES, INC. (US) 1988-09-07 EP disclosed
EP-0281367-A1 Substituted 1,2,4-triazolo[1,5-a]triazines as bronchodilators RIKER LABORATORIES, INC. (US) 1988-09-07 EP disclosed
US-4734413-A Substituted 1,2,4-triazolo[1,5-A]triazines as bronchodilators RIKER LABORATORIES, INC. (US) 1988-03-29 US disclosed
US-4734413-A Substituted 1,2,4-triazolo[1,5-A]triazines as bronchodilators RIKER LABORATORIES, INC. (US) 1988-03-29 US disclosed
US-4734413-A Substituted 1,2,4-triazolo[1,5-A]triazines as bronchodilators RIKER LABORATORIES, INC. (US) 1988-03-29 US disclosed
US-4617304-A VIRICIDE; HERPES MERCK & CO., INC. (US) 1986-10-14 US disclosed
EP-0159264-A2 Antiviral compounds MERCK & CO. INC. (US) 1985-10-23 EP disclosed